Nagalakshmi Nadiminty

Disclosure information not submitted.

Presentation(s):

• PD43-03: MCT inhibition synergizes with tyrosine kinase and mTOR inhibitor treatment in renal cell carcinoma

  Sunday, May 15, 2022
  9:50 AM – 10:00 AM